Annual report
6788.TEDINET S100YF0Y
Period2025-04-01 → 2026-03-31
Filed2026-06-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥22.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.3bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.1bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.1bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥36.1bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥35.4bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥31.5bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥29.0bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.6bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.6bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥9.8bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥25.5bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥25.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.6bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥20.8bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.7bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.8bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥11.9bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.9bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥883m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥551m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥432m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥553m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥998m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥500m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥568m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥269.58 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥292.41 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.51 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥214.78 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.58 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,193.56 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,125.8 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,911.21 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,743.39 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,585.01 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 65.8% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.5% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 777 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 735 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 663 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 650 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 608 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥16.3bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥15.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥15.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥14.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥3.1bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.1bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.2bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥2.6bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.1bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥23.2bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥22.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥21.1bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.1bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.5bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.9bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.7bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥19.3bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥18.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥18.0bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥17.3bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.7bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.8bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥339.09 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.17 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.11 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.93 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.33 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥130 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥130 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥120 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,592.2 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,461.1 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,344.3 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,261.46 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,172.44 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.2% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.2% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.2% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.4% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,656,780 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 349 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 342 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 326 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 325 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 321 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥14m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥1.4bn |
| Medical Relatedreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥322m |
| Medical Relatedreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥157m |
| Medical Relatedreportable segment | employees | at 2026-03-31 | 128 pure |
| Medical Relatedreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥3.0bn |
| Medical Relatedreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥3.0bn |
| Medical Relatedreportable segment | segment assets | at 2026-03-31 | ¥8.2bn |
| Medical Relatedreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥229m |
| Water Health Carereportable segment | capex | 2025-04-01 → 2026-03-31 | ¥276m |
| Water Health Carereportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥341m |
| Water Health Carereportable segment | employees | at 2026-03-31 | 649 pure |
| Water Health Carereportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥21.1bn |
| Water Health Carereportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥21.1bn |
| Water Health Carereportable segment | segment assets | at 2026-03-31 | ¥26.4bn |
| Water Health Carereportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥2.7bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥598m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥499m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥24.2bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥24.2bn |
| —segment total | segment assets | at 2026-03-31 | ¥34.7bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥2.9bn |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥15m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥1.4bn |
| Medical Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥710m |
| Medical Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥127m |
| Medical Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Medical Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Medical Relatedreportable segment | segment assets | at 2025-03-31 | ¥8.0bn |
| Medical Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥390m |
| Water Health Carereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥353m |
| Water Health Carereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥329m |
| Water Health Carereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥19.6bn |
| Water Health Carereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥19.6bn |
| Water Health Carereportable segment | segment assets | at 2025-03-31 | ¥25.9bn |
| Water Health Carereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥456m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥22.5bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥22.5bn |
| —segment total | segment assets | at 2025-03-31 | ¥33.9bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.3bn |
| Medical Relatedreportable segment | employees | at 2026-03-31 | 4 pure |
| Water Health Carereportable segment | employees | at 2026-03-31 | 345 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,550
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 24 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 28 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 28 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 27 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 26 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.642 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.782 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.999 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.035 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.168 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.020 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.079 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.525 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.502 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 2.022 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 6.2 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 8.0 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 13.98 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 15.00 | |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02333-000WaterHealthCareReportableSegmentsMember | 272000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E02333-000MedicalRelatedReportableSegmentsMember | 36000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 597678000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02333-000WaterHealthCareReportableSegmentsMember | 276018000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E02333-000MedicalRelatedReportableSegmentsMember | 321659000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8656780 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 8656780 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 8656780 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 8656780 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 9 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 16 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 59 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 42 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 12 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 6598 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 6736 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 10731 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 954 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 36006 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 2431 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 36 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 36321 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 86479 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 8880 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.1240 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0110 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.4163 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |